Memorial Sloan-kettering Cancer Center

Based in NY

🤖

AI Overview

With $4.3M in lobbying spend across 33 quarterly filings, Memorial Sloan-kettering Cancer Center is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.

$4.3M
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$390K
2019$560K
2020$350K
2021$480K
2022$690K
2023$580K
2024$560K
2025$660K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

  • Medicare coding and payment for advanced diagnostic laboratory tests, including NGS testing
  • Medicare coverage for NGS testing
  • Site neutral
  • CAR-T reimbursement
  • Injectable Opioid shortage
  • Opioids - impa
  • IV opioid shortages
  • CAR T-cell reimbursement
  • Site neutral
  • HR 1904, Medicare Access to Radiology Care Act of 2017
  • Next Generation Sequencing tests
  • CAR T reimbursement and access
  • site neutral payment
  • IPPS, PFS, and OPPS rules
  • NIH funding
  • Diagnostic Accuracy and Innovation Act (IVDs and LDTs)
  • drug shortages
  • CAR T reimbursement and access
  • site neutral payment
  • NIH funding
  • Diagnostic Accuracy and Innovation Act (IVDs and LDTs)
  • drug shortages

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.